Solventum Future Growth
Future criteria checks 1/6
Solventum's earnings are forecast to decline at 14.1% per annum while its annual revenue is expected to grow at 0.3% per year. EPS is expected to decline by 18.2% per annum. Return on equity is forecast to be 23.2% in 3 years.
Key information
-14.1%
Earnings growth rate
-18.2%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 0.3% |
Future return on equity | 23.2% |
Analyst coverage | Low |
Last updated | 10 May 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,348 | 878 | 961 | 1,505 | 3 |
12/31/2025 | 8,187 | 920 | 886 | 1,379 | 5 |
12/31/2024 | 8,087 | 905 | 765 | 1,203 | 3 |
3/31/2024 | 8,202 | 1,290 | 1,521 | 1,848 | N/A |
12/31/2023 | 8,197 | 1,346 | 1,625 | 1,915 | N/A |
9/30/2023 | 8,166 | 1,381 | 1,530 | 1,814 | N/A |
6/30/2023 | 8,101 | 1,256 | 1,542 | 1,817 | N/A |
3/31/2023 | 8,083 | 1,286 | 1,560 | 1,820 | N/A |
12/31/2022 | 8,130 | 1,343 | 1,428 | 1,679 | N/A |
12/31/2021 | 8,171 | 1,460 | 1,925 | 2,202 | N/A |
12/31/2020 | 7,281 | 1,138 | 1,755 | 2,026 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SOLV's earnings are forecast to decline over the next 3 years (-14.1% per year).
Earnings vs Market: SOLV's earnings are forecast to decline over the next 3 years (-14.1% per year).
High Growth Earnings: SOLV's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SOLV's revenue (0.3% per year) is forecast to grow slower than the US market (8.3% per year).
High Growth Revenue: SOLV's revenue (0.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SOLV's Return on Equity is forecast to be high in 3 years time (23.2%)